RAPT has flown under the radar in recent months. Wainwright initiated coverage this week with a buy and a $40 target stating that "the company has hit upon a novel way to address immune system dysregulation in both allergic disorders and cancer, Selvaraju tells investors in a research note." The consensus target is $37.83 meaning there is 100% of potential upside. A few key reasons I'm bullish:ġ) RAPT is down 65% from its highs in January and is it not directly impacted by covid.Ģ) It has begun to pick up momentum since the beginning of May which is likely to continue with multiple near - and medium - term catalysts.ģ) Analyst absolutely love this stock.
RAPT THERAPEUTICS FULL
I bought a full position this week at $19.50. Most information to help you learn and practice can be found in our wiki. Related Subreddits (see the rules above for related subs as well) Read here for more info.Īlmost any post related to stocks and investment is welcome on /r/stocks, including pre IPO news, futures & forex related to stocks, and geopolitical or corporate events indicating risks outside this is offtopic and can be removed. Consider posting to r/SPACs, r/pennystocks, r/weedstocks, or r/CanadianInvestor instead. No penny stock discussions, including OTC, microcaps, pump & dumps, low vol pumps and SPACs. Non-ETF-related Crypto goes on r/CryptoCurrencies info. No bitcoin or crypto discussions unrelated to stocks. Trolling, insults, or harassment, especially in posts requesting advice, will be removed. Posts regarding this topic will be automatically removed. The Robinhood app should be discussed in /r/Robinhood. Instead, advertise here.Ĭontext & effort must be provided empty posts or empty posts with links will be automatically removed. Spam, ads, solicitations (including referral links), and self-promotion posts or comments will be removed and you might get banned. To submit a comment you must have a 3 day old account, 10 comment karma 75 comment karma to post** Almost any post related to stocks is welcome please read the rules below:ĭisclose any related open positions when discussing a particular stock or financial instrument.ġb.
0 kommentar(er)
